IL-5 was significantly higher in presence of nasal polyps compared to CRSsNP and healthy controls and might therefore be a useful biomarker to predict ongoing type 2 inflammation in CRSsNP patients [32]. The gene discussed is IL5; the disease is chronic rhinosinusitis without nasal polyps.